CROI 2019 Program and Conference Information

Oral Sessions

20 LB QUANTIFICATION OF KSHV DNA AS A DIAGNOSTIC TEST FOR KAPOSI SARCOMA IN AFRICA Aggrey Semeere, Andrea Gardner, Megan Wenger, Priscilla Namaganda, Ryan Snodgrass, Varun Kopparthy, Esther Freeman, John Ssali, Mwebesa Bwana, Toby Maurer, Robert Lukande, Miriam Laker-Oketta, David Erickson, Ethel Cesarman, Jeffrey Martin 11:30

21

SPECIAL PRESENTATION: TWO NOVEL POTENTIAL THERAPEUTIC TARGETS IN THE KSHV LIFE CYCLE Thomas Schulz

11:45

Oral Abstract O-02 STRATEGIES FOR HIV CURE Room 6E Oral Abstract Moderators Denise C. Hsu, US Military HIV Research Program, Bangkok, Thailand Sarah B. Joseph, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 22

10:00 AM - 12:00 PM

TARGETING THE NONCANONICAL NF-ΚB PATHWAY REVERSES SIV LATENCY Maud Mavigner, Richard M. Dunham, Alyssa Brooks, Cristin Galardi, Gavin C. Sampey, Steven E. Bosinger, Thomas Vanderford, David M. Margolis, Guido Silvestri, Ann Chahroudi NONSUPPRESSIBLE VIREMIA ON ART FROM LARGE CELL CLONES CARRYING INTACT PROVIRUSES Elias K. Halvas, Kevin Joseph, Leah D. Brandt, Johannes C. Botha, Michele Sobolewski, Jana L. Jacobs, Brandon F. Keele, Mary F. Kearney, John M. Coffin, Jason W. Rausch, Shuang Guo, Xiaolin Wu, Stephen H. Hughes, John W. Mellors EX VIVO AND INVIVO EDITING OF THE SIV GENOME IN NONHUMAN PRIMATES BY CRISPR-CAS9 Tricia H. Burdo, Pietro Mancuso, Rafal Kaminski, Jennifer Gordon, Binhua Ling, Andrew MacLean, Kamel Khalili DELAYEDVIRAL REBOUND DURING ATI AFTER INFUSION OF CCR5 ZFN-TREATED CD4 T CELLS Pablo Tebas, Julie Jadlowsky, Pamela Shaw, Gary Lee, Dale Ando, Sukyung Kim, SoeYu Naing, Simon Lacey, Bruce L. Levine, Don L. Siegel, Carl H. June, James L. Riley MULTIDOSE IV ROMIDEPSIN: NO INCREASED HIV-1 EXPRESSION IN PERSONS ON ART, ACTG A5315 Deborah McMahon, Lu Zheng, Joshua C. Cyktor, Evgenia Aga, Bernard J. Macatangay, Catherine Godfrey, Michael Para, Ronald T. Mitsuyasu, Joseph Hesselgesser, Curtis Dobrowolski, Jonathan Karn, Edward P. Acosta, Rajesh T. Gandhi, John W. Mellors, for the A5315 Team PEMBROLIZUMAB INDUCES HIV LATENCY REVERSAL INHIV+ INDIVIDUALS ON ARTWITH CANCER Thomas S. Uldrick, Steven Fling, Scott V. Adams, Ajantha Solomon, Priscila H. Gonçalves, Nicolas Chomont, Rob Gorelick, Jeffrey D. Lifson, Robert Yarchoan, Martin “Mac” A. Cheever, Frank Maldarelli, Steven G. Deeks, Sharon R. Lewin, for the DARE and CITN-12 Study Teams

10:00

23

10:15

Oral Sessions • Tuesday 24 10:30

25

10:45

26

11:00

27

11:15

CROI 2019 32